Our results suggest that particle-activated mononuclear phagocytes can induce a change in the balance between bone formation and resorption by a number of mechanisms. J Bone Joint Surg [Br] 1997;79-B:988-94. 
Bone loss around prostheses can lead to loosening and eventual failure. [1] [2] [3] [4] Particles of prosthetic material are a major cause of loosening. The tissues surrounding the site of failed prostheses often contain mononuclear phagocytes (MNP) which have phagocytosed wear particles. 1, 2 In vivo 5 and in vitro 6 studies have
shown that MNP respond to wear particles by releasing a number of inflammatory mediators including prostaglandin E 2 (PGE 2 ), interleukins I and 6 (IL-1 and IL-6) and tumour necrosis factor (TNF). These mediators are important regulators of bone metabolism. 7, 8 Several recent studies have shown that particle-activated MNP release mediators which induce bone resorption in bone cultures. 9, 10 Bone stock is maintained by the balance between bone resorption and bone formation and therefore it is important to determine how the mediators released by particle-activated MNP influence bone formation. They may control the amount of bone by influencing bone formation by osteoblasts or affect bone resorption through osteoblasts which have a fundamental role in regulating bone resorption by osteoclasts.
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Titanium-6-aluminium-4-vanadium alloy (TiAlV) is used extensively in implants. Previous studies have shown that particles of TiAlV can induce the release of bone-resorbing mediators from rodent macrophages 6 and human monocytes. 12 Our aim was to investigate the effect of TiAlV particles on the interaction of human MNP and osteoblastic cells. We assessed the effects of media from cultures of particle-activated MNP and of specific blocking antibodies on osteoblastic cell growth, differentiation and the release of mediators of bone resorption from osteoblastic cells.
MATERIALS AND METHODS

Reagents.
Human recombinant IL-1␤ was a gift from the Otsuka Pharmaceutical Co Ltd (Tokushima, Japan). Human recombinant TNF␣, rabbit polyclonal antibodies to TNF␣, rabbit polyclonal antibodies to IL-1␤ and mouse monoclonal antibodies to IL-6 were purchased from the Genzyme Corporation (Cambridge, Massachusetts). Human recombinant IL-6 was purchased from Boehringer Mannheim GmbH (Mannheim, Germany) and PGE 2 and Escherichia coli 0111:B4 lipoplysaccharide (LPS) from the Sigma Chemical Company (Castle Hill, Australia). Generation of wear particles. Particles were produced using a method previously described in detail. 12 Briefly, small metal blocks were shaken inside hollowed-out components of hip prostheses to produce particles. Those of 0.5 to 3 m in diameter were isolated by differential centrifugation and carefully sized. The particle preparations and media used in these studies contained less than 10 pg/ ml of endotoxin as measured using the E-toxate kit from the Sigma Chemical Company. When 10 pg/ml of endotoxin was added to our MNP or bone cells the production of mediators, cell proliferation, 3 H-thymidine uptake and alkaline phosphatase expression were not affected, indicating that endotoxin contamination was not responsible for any of the effects seen in our study.
Particles of approximately 1 m in diameter are reported to be found near failed implants. 1, 2, 13, 14 From the amount of metal found in the tissues, 14, 15 and assuming an average particle size of 1 m, concentrations of TiAlV particles of up to 5 ‫ן‬ 10 8 particles per cubic centimetre may be expected. Previous studies have investigated the effects of TiAlV particles over a range of concentrations. 6 We considered that concentrations of 4 ‫ן‬ 10 7 and 1 ‫ן‬ 10 7 particles/ml were similar to those found in the tissues near articulating prostheses. Isolation and culture of MNP. Human mononuclear cells from eight healthy donors were isolated using ficol gradient as previously described. 16 We suspended 4 ‫ן‬ 10 6 cells in 1 ml of RPMI-1640 medium supplemented with 10% fetal calf serum, 5 g/ml of penicillin and 50 U/ml of streptomycin, and placed them in each well of a 16 mm flatbottomed 24-well tray (Falcon, Becton Dickinson Labware, New Jersey). After incubation at 37°C in 5% CO 2 for one hour the non-adherent cells were removed by washing with Hanks' balanced salt solution. The adherent cells were then incubated in 1 ml of the RPMI medium containing TiAlV particles or 5 g/ml of LPS. After 48 hours the supernatants were sampled and centrifuged at 4000 g for ten minutes to remove any particles. The samples were then tested for levels of inflammatory mediators and used as conditioned media for the bone-cell cultures, either immediately, or after storage at -70°C. Mediator assays. The level of PGE 2 was determined using a competitive radioimmunoassay. 17 3 H-labelled PGE 2 was purchased from Amersham, Buckinghamshire, UK and unlabelled PGE 2 from the Sigma Chemical Company. The PGE 2 antisera was a gift from Dr R. Seamark, Department of Obstetrics and Gynaecology, University of Adelaide, Australia. Commercial immunoassay kits were used to measure the levels of cytokines in the supernatants from cell culture. TNF␣ and IL-6 kits were purchased from the Genzyme Corporation (Cambridge, Massachusetts) and Medgenix Diagnostics (Fleurus, Belgium). IL-1␤ kits were purchased from the Cayman Chemical Company (Ann Arbor, Michigan). Assessment of osteoblastic cells. These were obtained by outgrowth of cells from explants of healthy bone removed at the time of primary hip replacement 18 Labware, New Jersey). Minimal essential media (alpha) supplemented with 10% fetal calf serum, 5 g/ml of penicillin, 50 U/ml of streptomycin and 1% ascorbate-2-phosphate was used for all bone cell cultures. When the cells reached confluence they were detached from the bottom of the flasks using collagenase, pepsin and trypsin and 2 ‫ן‬ 10 4 cells in 1 ml of media were allowed to adhere to the bottom of the wells of 24-well trays for 24 hours. Mediators or conditioned media (at 1/5 dilution) from eight donors, with or without antibodies to cytokines, were then added. In other experiments conditioned media were obtained from cultures of MNP from four healthy donors.
Each conditioned medium was then tested on osteoblastic cells derived from four individuals. Thus, a total of 16 separate tests were carried out.
To assess cell numbers and alkaline phosphatase expression, medium was replaced every three days for up to 14 days when the cells were removed by collagenase, pepsin and trypsin treatment. The numbers and percentage of cells staining positive for the presence of alkaline phosphatase were assessed using a diagnostics kit (Sigma Chemical Company, Castle Hill, Australia).
After 48 hours 1 Ci 3 H-thymidine was added to the bone cells to allow the incorporation of thymidine into DNA to be measured 24 hours later. Cells were washed three times in phosphate-buffered saline-containing cold thymidine. They were then detached by treatment with trypsin/EDTA solution at 37°C for 30 minutes. The cells were removed by washing out the well twice with a solution of 1 mg/ml of bovine serum albumin. The DNA in these wash-outs was then precipitated overnight using 7.5% trichloroacetic acid. The precipitate was washed three times in 7.5% trichloroacetic acid before being dissolved in 0.5 ml of sodium hydroxide, placed in 4 ml of scintillation fluid and counted on a scintillation counter (Beckman LS2800; Beckman Instruments Inc, Fullerton, California). Blocking the activity of cytokines with antibodies. Antibodies were incubated with conditioned media at 37°C for four hours and the mixture placed on the bone cell cultures. The concentration of antibodies required to inhibit the biological activity of cytokines present in the particleconditioned media was determined using specific biological assays. 19 The activities of IL-1 and TNF were assayed by assessing their ability to inhibit the proliferation of the A375 and L929 cell lines respectively and IL-6 activity by using IL-6-dependent 7TD1 cells. The concentrations of the blocking antibodies which we used blocked more than 95% of the biological activity in the conditioned media. Experiments with recombinant cytokines in similar assays also showed that the antibodies blocked only the particular cytokine to which they were raised.
Statistics. We used program 5V from the BMDP (UCLA) 1993 statistical software package (BMDP Statistical Software Inc, Los Angeles, California) for the analysis. The sets of measurements using monocytes or bone cells from the same individuals could be correlated. Therefore a repeated measures of analysis of variance was used to test for differences in response. Replicate data from each individual also allowed estimation of treatment effects. The data for Tables I, II and IV were analysed using repeated measures analysis of variance using within-subject factor for treatments. An unstructured covariance matrix was used to allow for the most general form of correlations in Table IV . An unstructured covariance matrix was also used in Tables  I and II , but with allowance for replicate measurements. Each variable was analysed separately for the experiments described in Table III . A repeated measures analysis of variance was used with within-subject factors of the treatments and the blood mononuclear cells from the four donors used in the experiment. A covariate to adjust for the baseline level of response for the four different donor bone cells was also included.
In all the experiments we considered a meaningful differ- 3.9 ± 0.9 9.9 ± 1.8 289.0 ± 143.0 † 23.8 ± 7.9 † * results are shown only for the experiments using the osteoblastic cells from the four out of eight donors which produced detectable levels of TNF␣ (> 10 pg/ml) † p < 0.01 when compared with treatment with media from MNP with no particles ence in response to be a change of more than 20% from control values. A p value of less than 0.01 was considered significant.
RESULTS
Mediators induced by particles. Detectable levels of IL-1␤, IL-6, TNF␣ and PGE 2 were released by unstimulated MNP during culture for 48 hours (Table I) . A concentration of 4 ‫ן‬ 10 7 particles/ml of TiAlV elevated the release of all the mediators approximately fivefold. By contrast, 5 g/ml of LPS enhanced the levels of all mediators released by more than 100-fold. TiAlV particles at 1 ‫ן‬ 10 7 particles/ml also stimulated mediator production, but at levels much lower than those stimulated by LPS or 4 ‫ן‬ 10 7 particles/ml of TiAlV. We noted differences in the relative amounts of mediators released by stimulation with particles and LPS; the latter stimulated the release of similar amounts of IL-1␤ and TNF␣, but 4 ‫ן‬ 10 7 particles/ml of TiAlV stimulated the release of six times more TNF␣ than IL-1␤. Regulation of osteoblastic cell growth by recombinant cytokines and PGE 2 . Table II shows the effects of recombinant cytokines, PGE 2 and LPS on the osteoblastic cells. These were tested at levels similar to those measured in the MNP cultures to allow direct comparison with endogenously produced cytokines (Table III) Table II ). When the activity of TNF␣ in the particle-conditioned media was blocked with antibodies, 3 H-thymidine uptake and total cell numbers were restored to levels that were not statistically different from those in media alone. The numbers and proportion of AP+ve cells, however, increased markedly. Inhibition of proliferation by the particle-conditioned media was mainly due to TNF␣ as only TNF␣ antibodies reversed the inhibition of 3 H-thymidine uptake (Fig. 1) .
Release of bone-resorbing mediators by osteoblastic cells. Media from MNP activated by 4 ‫ן‬ 10 7 particles/ml of TiAlV consistently stimulated the release of IL-6 and PGE 2 from osteoblastic cells (Table IV) . Media from the particle-activated MNP did not stimulate IL-1␤ release above the low levels which were released from unstimulated cells. TNF␣ release was dependent on the donor; levels below reliable detectable limits of our immunoassay (<10 pg/ml) were found in four of eight bone-cell cultures.
Media from particle-activated MNP further enhanced the 991 REGULATION OF BONE CELLS BY PARTICLE-ACTIVATED MONONUCLEAR PHAGOCYTIC CELLS VOL. 79-B, NO. 6, NOVEMBER 1997 Fig. 1 The effect of conditioned media on the mean (± SEM) uptake of 3 Hthymidine by osteoblastic cells. The change in 3 H-thymidine uptake is expressed on the y-axis. The mean level incorporated by the osteoblastic cells in the absence of conditioned media was given a value of 0. Experiments were carried out in the presence (+) or absence (-) of blocking antibodies. release of TNF␣ in cultures which produced detectable levels.
Antibodies to both IL-1␤ and TNF␣ inhibited PGE 2 production by cells stimulated by particle-conditioned media while IL-6 antibodies had no effect (Fig. 2) . Production of IL-6 was strongly inhibited by antibodies to IL-1␤ and less by TNF␣ antibodies (Fig. 3) . IL-1␤ and TNF␣ antibodies together did not inhibit IL-6 production any more than IL-1␤ antibodies alone.
DISCUSSION
The direct effect of wear particles on bone cells cannot be discounted. 20 Results from similar studies 21 in vitro and histological evidence suggest that the major effects of wear particles are mediated by cells of the macrophage lineage. 1, 2, 5 Our study shows that wear particles can activate MNP to release mediators involved in osteoblast development. Osteoblasts have a limited life span and continual recruitment of mature osteoblasts is necessary to maintain bone formation. Therefore factors which inhibit osteoblast proliferation and differentiation released from MNP can reduce bone formation. Our findings suggest that TNF␣ is the most active inhibitor of osteoblastic cell proliferation and differentiation released from particle-activated MNP. IL-1␤ can also regulate osteoblastic cells but, in contrast to TNF␣, it stimulates osteoblastic cell proliferation and differentiation. Different effects of IL-1␤ and TNF␣ have been reported depending on culture conditions and the types of osteoblastic cell population used. 22 Our findings, however, are consistent with several other reports. [23] [24] [25] [26] Inhibition of TNF␣ activity in the particle-conditioned media restored the proliferation of bone cells to normal levels and produced a marked increase in the proportion of AP+ve cells. This is probably due to the IL-1␤ in the conditioned media which can now stimulate bone cell differentiation in the absence of the dominant inhibition by TNF␣. The relative levels of these two cytokines produced by particle-activated MNP near bone may be important in determining the numbers of mature osteoblasts. This can vary, depending on the type of stimulus that the MNP receives. TiAlV wear particles may be harmful to bone formation as they stimulate more TNF␣ than IL-1␤ (Table I) . The osteoblastic cells which we used were a heterogeneous population which included those which can form mineralised bone in long-term culture. 27 The individuals from which the osteoblastic cells were isolated may not be representative of the general population and their cells may differ from cells from healthy individuals. They may, however, better reflect the characteristics of human osteoblasts and osteoblast precursors than the immortal rodent osteoblast cell lines which have been widely used in the past. Bone formation and resorption are closely linked and osteoclasts appear to require the co-operation of osteoblasts for complete activity. 11 Mediators regulating osteoclast functions released by osteoblastic cells are likely to play an important role in regulating bone loss. We found that very low levels of IL-1␤ were released by the osteoblastic cells. A previous report has indicated that IL-1 is produced by osteoblastic cells, but it was detected using the thymocyte proliferation assay in which TNF and IL-6 also have activity. 28 There have been conflicting reports on the ability of osteoblastic cells to produce TNF␣. 23, 29 We noted a large variation in the levels of TNF␣ produced. A recent study The effect of conditioned media on the mean (± SEM) release of PGE 2 by osteoblastic cells. Experiments were carried out in the presence (+) or absence (-) of blocking antibodies. Fig. 3 The effect of conditioned media on the mean (± SEM) release of IL-6 by osteoblastic cells. Experiments were carried out in the presence (+) or absence (-) of blocking antibodies.
using sensitive PCR techniques showed that TNF␣ was not detected in bone cells from normal patients, but was seen in two of four samples of Pagetoid bone. 30 Production of TNF␣ by osteoblastic cells may be extremely variable and depend upon the individual from which the cells have been derived. The potent effects of TNF␣ on bone metabolism mean that it should be closely studied in relation to this and other bone diseases. Two recent studies using particles of orthopaedic cement (PMMA) 31, 32 have attempted to determine the role of osteoblasts in mediating osteoclastic bone resorption. Both used cell lines and the results indicated that soluble factors released from osteoblasts have a significant role in bone loss induced by implant materials. Our findings using human osteoblastic cells support this concept and show that IL-6, TNF␣ and PGE 2 can be released from human osteoblastic cells stimulated by particle-activated MNP. IL-1␤ and TNF␣ are the major mediators released by the particleactivated MNP which stimulate the release of IL-6 and PGE 2 from osteoblastic cells. While other MNP-derived factors are known to regulate osteoblastic cells, 33 the use of blocking antibodies in our study shows that IL-1␤ and TNF␣ are potentially the most important factors released by MNP after particle stimulation. Elevated levels of IL-1␤, IL-6, TNF␣ and PGE 2 are reported in several diseases in which MNP become activated. High levels of one or more of these mediators are found in the tissues near bone in rheumatoid arthritis and osteoarthritis. 34, 35 Bone loss and abnormal bone remodelling occur in both diseases. The ability of TNF␣ and IL-1␤ to regulate osteoblasts numbers and stimulate release of boneresorbing mediators indicates that they may also have a significant role in abnormal bone metabolism in a variety of diseases.
Our aim was to understand better the processes involved in bone loss near artificial joints. We found that particleactivated MNP have the potential to reduce numbers of bone-forming cells. In addition, osteoblastic cells may amplify bone loss stimulated by MNP by releasing boneresorbing mediators in response to particle-activated MNP. Our study has identified TNF␣ and, to a less extent, IL-1␤ as the most active mediators in these processes.
